Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-19

FDA Approved: SAMSCA — Original Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Samsca (tolvaptan) from Otsuka America for the treatment of clinically significant hyponatremia in adults, including hyponatremia associated with S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Samsca (tolvaptan)

Snippet

ORIG AP for SAMSCA (TOLVAPTAN)